A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Olmesartan Medoxomil tablets 40 mg relative to OLMETEC (TABLETS 40 MG) in healthy Thai volunteers under fasting condition
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Mirtazapine ODT 30 mg relative to Remeron SolTab 30 mg in healthy Thai volunteers under fasting condition
A Bioequivalence study of a randomized, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Lacosamide Film Coated Tablet 100 mg (Test) relative to Vimpat Film Coated Tablet 100 mg (Reference) in healthy Thai adult volunteers under fasting condition.
100 Clinical Results associated with Bio-innova Co., Ltd
0 Patents (Medical) associated with Bio-innova Co., Ltd
100 Deals associated with Bio-innova Co., Ltd
100 Translational Medicine associated with Bio-innova Co., Ltd